article

1. Antiplatelet and Anticoagulant Use in Nursing Home Residents With Atrial Fibrillation..  JAMA internal medicine.  2024
2. Improving the value and interpretation of observational studies comparing treatment effects of osteoporosis medications depends on standardized reporting of methods..  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.  39:807-809. 2024
3. Risk factors for urinary tract infections among nursing home residents initiating sodium-glucose cotransporter-2 inhibitors..  Journal of the American Geriatrics Society.  2024
4. Use of electronic health record data to examine administrations of pro re nata analgesics during hip fracture post-acute care..  Pharmacoepidemiology and drug safety.  33:-. 2024
5. Comparative safety and cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in nursing homes..  Diabetes, obesity & metabolism.  26:3403-3417. 2024
6. COVID-19 Vaccines: Moderna And Pfizer-BioNTech Use Varied By Urban, Rural Counties..  Health affairs (Project Hope).  43:659-665. 2024
7. COVID-19 and Influenza Vaccine Coadministration Among Older U.S. Adults..  American journal of preventive medicine.  67:67-78. 2024
8. Sliding Scale Insulin Use in Nursing Homes Before and After Onset of the COVID-19 Pandemic..  Journal of the American Medical Directors Association.  25:459-464. 2024
9. Fall risk and cardiovascular outcomes of first-line antihypertensive medications in nursing home residents..  Journal of the American Geriatrics Society.  72:682-692. 2023
10. Methodological guidance for the use of real-world data to measure exposure and utilization patterns of osteoporosis medications..  Bone reports.  -. 2023
11. Benefits and Harms of Standard Versus Reduced-Dose Direct Oral Anticoagulant Therapy for Older Adults With Multiple Morbidities and Atrial Fibrillation..  Journal of the American Heart Association.  12:-. 2023
12. Data resource profile: COVid VAXines effects on the aged (COVVAXAGE)..  International journal of population data science.  8:-. 2023
13. Racial and ethnic disparities in COVID-19 booster vaccination among U.S. older adults differ by geographic region and Medicare enrollment..  Frontiers in public health.  -. 2023
14. Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults..  JAMA network open.  6:-. 2023
15. Evaluation of post-acute care and one-year outcomes among Medicare beneficiaries with hip fractures: a retrospective cohort study..  BMC medicine.  21:-. 2023
16. Trends in COVID-19-Related Medication Use in US Nursing Homes, 2018-2022..  Journal of the American Medical Directors Association.  24:1120-1126.e1. 2023
17. Adoption of sodium-glucose cotransporter-2 inhibitors among prescribers caring for nursing home residents..  Journal of the American Geriatrics Society.  71:2585-2592. 2023
18. Post-Acute Care Setting After Hip Fracture Hospitalization and Subsequent Opioid Use in Older Adults..  Journal of the American Medical Directors Association.  24:971-977.e4. 2023
19. Comparative safety of sulfonylureas among U.S. nursing home residents..  Journal of the American Geriatrics Society.  71:1047-1057. 2022
20. Web Exclusive. Annals On Call - Time for a Bisphosphonate Holiday?.  Annals of internal medicine.  175:-. 2022
21. Electronic Health Records to Rapidly Assess Biosimilar Uptake: An Example Using Insulin Glargine in a Large U.S. Nursing Home Cohort..  Frontiers in pharmacology.  -. 2022
22. Trends in Canadian prescription drug purchasing: 2001-2020..  Journal of pharmaceutical policy and practice.  15:-. 2022
23. Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study..  Rheumatology advances in practice.  6:-. 2022
24. Comparisons of Insulin Spending and Price Between Canada and the United States..  Mayo Clinic proceedings.  97:573-578. 2022
25. Comparative Fracture Risk During Osteoporosis Drug Holidays After Long-Term Risedronate Versus Alendronate Therapy : A Propensity Score-Matched Cohort Study..  Annals of internal medicine.  175:335-343. 2022
26. When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis..  Frontiers in endocrinology.  -. 2021
27. Hospital pharmacist discharge care is independently associated with reduced risk of readmissions for patients with chronic obstructive pulmonary disease: A propensity-matched cohort study..  Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.  155:101-106. 2021
28. Global adverse events reported for direct-acting antiviral therapies for the treatment of hepatitis C: an analysis of the World Health Organization VigiBase..  European journal of gastroenterology & hepatology.  33:e1017-e1021. 2021
29. Comparison of public and private payments for direct-acting antivirals (DAAs) across Canada..  Canadian liver journal.  4:426-429. 2021
30. Observational study methods used to assess pharmacotherapy effects of type 2 diabetes on fracture risk: a scoping review protocol..  JBI evidence synthesis.  19:3129-3141. 2021
31. Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects..  Frontiers in pharmacology.  -. 2021
32. Control yourself: ISPE-endorsed guidance in the application of self-controlled study designs in pharmacoepidemiology..  Pharmacoepidemiology and drug safety.  30:671-684. 2021
33. Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making..  Journal of clinical medicine.  10. 2021
34. Addressing the Challenges of Precepting Students Enrolled in Remote Research Advanced Pharmacy Practice Experiences..  American journal of pharmaceutical education.  85:-. 2021
35. Over half of seniors who start oral bisphosphonate therapy are exposed for 3 or more years: novel rolling window approach and patterns of use..  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.  32:1413-1420. 2021
36. Response to: Challenges to the Possible Use of Bisphosphonates in Early-Stage Osteoarthritis..  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.  36:815-816. 2020
37. Bisphosphonate Use Is Protective of Radiographic Knee Osteoarthritis Progression Among those With Low Disease Severity and Being Non-Overweight: Data From the Osteoarthritis Initiative..  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.  35:2318-2326. 2020
38. Derivation and assessment of the opioid use disorder severity scale: prediction of health, psychological and social adjustment problems..  The American journal of drug and alcohol abuse.  46:699-707. 2020
39. Further Evidence to Monitor Long-term Proton Pump Inhibitor Use..  JAMA network open.  2:-. 2019
40. Time trends in oral bisphosphonate initiation in Ontario, Canada over 20 years reflect drug policy and healthcare delivery changes..  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA.  30:2311-2319. 2019
41. Evaluation of targeted human papillomavirus vaccination education among undergraduate college students..  Journal of American college health : J of ACH.  67:781-789. 2018